College of Pharmacy, Gannan Medical University, Ganzhou, 341000, China.
Food Funct. 2020 Oct 21;11(10):8472-8492. doi: 10.1039/d0fo01598a.
Diosmin is a famous natural flavonoid for treating chronic venous insufficiency and varicose veins. Recently, extensive study has indicated that diosmin possesses diverse pharmacological activities, including anti-inflammation, anti-oxidation, anti-diabetes, anti-cancer, anti-microorganism, liver protection, neuro-protection, cardiovascular protection, renoprotection, and retinal protection activities. Due to its low water solubility, diosmin is dramatically limited in clinical application. Expectedly, many potential strategies have been developed for improving its pharmacokinetic values and bioavailability. This health-benefiting compound has been explored as the major component of Daflon and micronized purified flavonoid fraction (MPFF), which have been used in clinics to improve micro-circulation. However, no specific drug targets for diosmin are reported, although some potential factors have been involved in screening, such as P-glycoprotein (P-gp), IKKβ, acetylcholinesterase (AChE), and aldose reductase (AR). More investigations on the underlying mechanisms of diosmin in mediating cellular processes with high specificity is still needed.
地奥司明是一种治疗慢性静脉功能不全和静脉曲张的著名天然黄酮类化合物。最近,广泛的研究表明,地奥司明具有多种药理活性,包括抗炎、抗氧化、抗糖尿病、抗癌、抗微生物、保肝、神经保护、心血管保护、肾保护和视网膜保护作用。由于其水溶性低,地奥司明在临床应用中受到极大限制。预计已经开发了许多潜在的策略来提高其药代动力学值和生物利用度。这种对健康有益的化合物已被探索作为达肝素和微粒化纯化黄酮类(MPFF)的主要成分,已在临床上用于改善微循环。然而,尽管已经涉及到一些潜在的筛选因素,如 P-糖蛋白(P-gp)、IKKβ、乙酰胆碱酯酶(AChE)和醛糖还原酶(AR),但尚未报道地奥司明的特定药物靶点。需要对地奥司明在介导具有高特异性的细胞过程中的潜在机制进行更多的研究。